Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Grifols SA (GRF SM)
Watchlist
67
Analysis
Health Care
•
Spain
Grifols S.A. develops, manufactures, and markets plasma derivatives, IV Therapy, enteral nutrition, diagnostic systems, and medical materials.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
China Biologic Products
•
19 Mar 2019 03:30
China Blood Products: Deals Highlight Values
Grifols SA (GRF SM) and Shanghai RAAS Blood Products Co Ltd (002252.SZ) recently announced an asset exchange that effectively combines the...
Kemp Dolliver, CFA
580 Views
Share
bullish
•
CSL Ltd
•
10 Oct 2017 09:55
Not All Players Are Equal in the Plasma Industry
According to Allied Market Research, the IVIG (intravenous IG) market was valued at US$7.86bn and is expected to reach US$12.36bn by 2022. IVIG is...
JCP Investment Partners
Follow
313 Views
Share
bullish
•
Thematic (Sector/Industry)
•
30 Jan 2017 13:50
Relapsed/Refractory Acute Myeloid Leukemia (R/R AML)
AML represents one of the largest hematologic cancer populations with one of the worst survival rates. Global prevalence is expected to increase at...
Dion Stéfan Büchner M.D., FCAP
524 Views
Share
bullish
•
Thematic (Sector/Industry)
•
13 Dec 2016 11:44
American Society of Hematology- (ASH) Annual Conference (2016) Review
We reviewed data presented at the American Society of Hematology (ASH) conference in San Diego last week with a focus on the evolving treatment...
Dion Stéfan Büchner M.D., FCAP
364 Views
Share
bullish
•
Thematic (Sector/Industry)
•
03 Dec 2016 18:43
American Society of Hematology (ASH) -Annual Conference (2016) Preview
With a focus on novel mechanisms of action (MoA), we highlight select non-Hodgkin's lymphoma (NHL) and Multiple Myeloma (MM) related abstracts at...
Dion Stéfan Büchner M.D., FCAP
227 Views
Share
First
Previous
10
11
12
13
14
Next
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.44.3
x